Evidence map›Paper›PMID 27545877›Full record

ArticleCell reports2016

Stimulation of Slack K(+) Channels Alters Mass at the Plasma Membrane by Triggering Dissociation of a Phosphatase-Regulatory Complex.

Matthew R Fleming, Maile R Brown, Jack Kronengold, Yalan Zhang, David P Jenkins, Gulia Barcia, Rima Nabbout, Anne E Bausch, Peter Ruth, Robert Lukowski and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Journal of medicinal chemistry · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. KNeurobiology of disease · 2022
    Article
  15. Review
  16. Double-edged Role of KCurrent neuropharmacology · 2022
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Matthew R FlemingDepartment of Pharmacology, Yale School of Medicine, New Haven, CT 06520, USA.
Maile R BrownDepartment of Pharmacology, Yale School of Medicine, New Haven, CT 06520, USA.
Jack KronengoldDepartment of Pharmacology, Yale School of Medicine, New Haven, CT 06520, USA.
Yalan ZhangDepartment of Pharmacology, Yale School of Medicine, New Haven, CT 06520, USA.
David P JenkinsDepartment of Pharmacology, Yale School of Medicine, New Haven, CT 06520, USA.
Gulia BarciaDepartment of Pediatric Neurology, Centre de Reference Epilepsies Rares, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), 75015 Paris, France.
Rima NabboutDepartment of Pediatric Neurology, Centre de Reference Epilepsies Rares, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), 75015 Paris, France.
Anne E BauschDepartment of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy University of Tübingen, 72076 Tübingen, Germany.
Peter RuthDepartment of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy University of Tübingen, 72076 Tübingen, Germany.
Robert LukowskiDepartment of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy University of Tübingen, 72076 Tübingen, Germany.
Dhasakumar S NavaratnamDepartment of Neurology, Yale School of Medicine, New Haven, CT 06520, USA.
Leonard K KaczmarekDepartment of Pharmacology, Yale School of Medicine, New Haven, CT 06520, USA; Department of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, CT 06520, USA. Electronic address: leonard.kaczmarek@yale.edu.
Yale University · USUniversity of Tübingen · DEAssistance Publique – Hôpitaux de Paris · FRHôpital Necker-Enfants Malades · FR

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale/NIDA Neuroproteomics Research CenterP30DA018343 · NIDA · YALE UNIVERSITY · PI Marina R Picciotto · 2004 to 2026
$37.1M
EXPRESSION OF ION CHANNELS IN THE AUDITORY SYSTEMR01DC001919 · NIDCD · YALE UNIVERSITY · PI KACZMAREK, LEONARD K · 1993 to 2025
$9.7M
Studies on hair cell BK channelsR01DC007894 · NIDCD · YALE UNIVERSITY · PI NAVARATNAM, DHASAKUMAR S · 2006 to 2017
$3.6M
Cellular regulation of Sodium-activated Ion ChannelsR01HD067517 · NICHD · YALE UNIVERSITY · PI KACZMAREK, LEONARD K · 2011 to 2015
$1.7M
NCATS NIH HHS UL1 TR001863NICHD NIH HHS R01 HD067517NIDA NIH HHS P30 DA018343NIDCD NIH HHS R01 DC001919NIDCD NIH HHS R01 DC007894
6 · The paper itself

Abstract

Human mutations in the cytoplasmic C-terminal domain of Slack sodium-activated potassium (KNa) channels result in childhood epilepsy with severe intellectual disability. Slack currents can be increased by pharmacological activators or by phosphorylation of a Slack C-terminal residue by protein kinase C. Using an optical biosensor assay, we find that Slack channel stimulation in neurons or transfected cells produces loss of mass near the plasma membrane. Slack mutants associated with intellectual disability fail to trigger any change in mass. The loss of mass results from the dissociation of the protein phosphatase 1 (PP1) targeting protein, Phactr-1, from the channel. Phactr1 dissociation is specific to wild-type Slack channels and is not observed when related potassium channels are stimulated. Our findings suggest that Slack channels are coupled to cytoplasmic signaling pathways and that dysregulation of this coupling may trigger the aberrant intellectual development associated with specific childhood epilepsies.

Indexed as

Signal TransductionAdaptor Proteins, Signal TransducingAnimalsBiosensing TechniquesBithionolBridged Bicyclo Compounds, HeterocyclicCell MembraneCerebral CortexFragile X Messenger Ribonucleoprotein 1Gene Expression RegulationHEK293 CellsHumansIon TransportMiceMice, KnockoutMicrofilament ProteinsAdaptor Proteins, Signal TransducingBithionolBridged Bicyclo Compounds, HeterocyclicCYFIP1 protein, humanFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1KCNT1 protein, humanlatrunculin BMicrofilament ProteinsNerve Tissue ProteinsPHACTR1 protein, humanPotassium ChannelsPotassium Channels, Sodium-ActivatedRNA, Small InterferingThiazolidines

Identifiers

PMID27545877
PMCPMC5123741
OpenAlexW2510712109

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.